Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1715152

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of making laser treatment for prostate cancer available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	24459
answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) has considered developing interventional procedures guidance on magnetic resonance imaging guided laser interstitial thermal therapy for early prostate cancer. However, it is awaiting publication of further evidence before being brought forward. The NICE has not made any recommendations on laser treatment for prostate cancer.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/05/2024 12:49:55 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1715164

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with type 2 diabetes in the last three years, broken down by (a) age and (b) gender.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	24471
answer	answer is ministerial correction date of answer 20/05/2024 answer text <p>Data relating to the incidence and prevalence of diabetes in England and Wales is captured by the National Diabetes Audit Report. The most current figures published cover the period 2017-18 to 2021-22, which have been published online and can be found on the NHS Digital website:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-care-processes-and-treatment-targets-2021-22-full-report/section-1---incidence-and-prevalence-17-18---21-22-copy" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-care-processes-and-treatment-targets-2021-22-full-report/section-1---incidence-and-prevalence-17-18---21-22-copy</a>.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/05/2024 13:57:13 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1715203

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Streptococcus: Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she expects to receive the outcome of the Group B Streptococcus trial before the House rises for the Summer adjournment.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	24400
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The clinical and cost-effectiveness of testing for Group B Streptococcus: a cluster randomised trial with economic and acceptability evaluations trial current contract end date is 31 August 2025, therefore results will not be available before the House of Commons rises for the summer adjournment. The trial has finished recruiting participants and data extraction and analysis continues and the results will be available once both are completed. As with all research funded through the National Institute for Health and Care Research, we expect findings to be submitted to the Department, and in the case of this trial, to the UK National Screening Committee (UK NSC) hosted by the Department. The UK NSC stands ready to review the findings of this research as soon as the results are shared.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 07/05/2024 08:33:56 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1409 label Biography information for Mr Gregory Campbell

1715213

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure myalgic encephalomyelitis receives a proportionate share of National Institute for Health and Care Research funding.
tabling member constituency	Midlothian
tabling member printed	Owen Thompson
uin	24494
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including myalgic encephalomyelitis. These applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality. In all areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 24495 question first answered 07/05/2024 09:31:25 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4482 label Biography information for Owen Thompson

1715220

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will instruct the National Institute for Health and Care Research to increase the level of funding available for myalgic encephalomyelitis research.
tabling member constituency	Midlothian
tabling member printed	Owen Thompson
uin	24495
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including myalgic encephalomyelitis. These applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality. In all areas, the amount of NIHR funding depends on the volume and quality of scientific activity.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 24494 question first answered 07/05/2024 09:31:25 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4482 label Biography information for Owen Thompson

1715240

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her planned timetable is for publication of the implementation plan for the Medical Technology Strategy.
tabling member constituency	Bristol South
tabling member printed	Karin Smyth
uin	24491
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The Government published the Medical Technology Strategy: One Year On policy paper on 9 April 2024. This paper outlines key achievements since the publication of the inaugural Medical Technology Strategy in February 2023. It also outlines our plan to streamline and integrate the innovation pathway, detailing next steps and milestones.</p><p>The paper reiterated the Government’s commitment to collaborate with key stakeholders to deliver our plan, including industry, patient groups, clinicians and the wider health and social care system.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 07/05/2024 08:29:42 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4444 label Biography information for Karin Smyth

1715246

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liver Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the implications for her policies of the development of intelligent liver function tests by the University of Dundee; and if she will make it her policy to increase the rollout of these tests in areas with the highest levels of liver disease in England.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	24489
answer	answer is ministerial correction date of answer 09/05/2024 answer text <p>The Government is working with the National Health Service to support earlier diagnosis of liver disease, and to identify patients at risk. This includes plans agreed as part of the £2.3 billion diagnostics transformation programme, to upgrade the digital capabilities of laboratories across the country and ensure that they have the capability required to offer Intelligent Liver Function Tests (iLFTs).</p><p>NHS England is reviewing the liver fibrosis pathways, and looking at developing a diagnosis pathway starting in primary care that will make use of both laboratory-based tests, such as iLFTs, and community diagnostic centres. The Government will make a further assessment of this work once it is complete, including the benefits of an increased rollout of iLFTs across England.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 09/05/2024 12:55:48 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4430 label Biography information for Alison Thewliss

1715255

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Community Diagnostic Centres: Osteoporosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many community diagnostic centres are providing bone density scans.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	24497
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>As of May 2024, 19 community diagnostic centres (CDCs) are providing bone density scans, also known as DEXA scans. A total of 35 CDCs are planning to provide these scans in 2024/25.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/05/2024 15:15:57 answering member 4044 label Biography information for Andrew Stephenson previous answer version 32815 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527
tabling member	4504 label Biography information for Wes Streeting

1715256

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Community Diagnostic Centres: Osteoporosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of bone density scans conducted in community diagnostic centres in the last 12 months.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	24498
answer	answer is ministerial correction date of answer 08/05/2024 answer text <p>Data on the number of bone density scans, also known as DEXA scans, conducted in community diagnostic centres, is publicly available in the NHS Diagnostics Waiting Times and Activity (DM01) dataset. This data has been published monthly since March 2023, and is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-and-activity/monthly-diagnostics-waiting-times-and-activity/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/diagnostics-waiting-times-and-activity/monthly-diagnostics-waiting-times-and-activity/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 08/05/2024 08:48:34 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4504 label Biography information for Wes Streeting

1715257

registered interest
date	01/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of scans for suspected prostate cancer performed by the NHS in each of the last five years.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	24499
answer	answer is ministerial correction date of answer 08/05/2024 answer text <p>While some data on scanning of the prostate is available from the Diagnostic Imaging Dataset, it does not distinguish between scans for non-cancer indications, scans for suspected cancer, namely cancer diagnosis, and scans to inform staging and treatment planning for cancer which is already diagnosed.</p><p>Screening for the most common cancer in men, prostate cancer, is complex but we are backing groundbreaking trials to improve diagnostic processes and save thousands more lives. In 2021, 43,378 men were diagnosed with prostate cancer, a 9% decrease compared to 2019. The recently announced TRANSFORM trial, which will be led by Prostate Cancer UK and supported by £16 million of Government funding, aims to find the best way to screen for prostate cancer. The trial will cover the whole of the United Kingdom, although final decisions on specific locations are yet to be taken. The UK National Screening Committee will be reviewing the evidence that is published by this study, which will help to inform any future recommendation on creating a national screening programme for prostate cancer.</p><p>To support faster diagnosis, NHS England is streamlining cancer pathways and in October 2022 introduced the best practice timed pathway for prostate cancer. This guidance recommends those with suspected prostate cancer undertake multi-parametric magnetic resonance imaging before biopsy, which ensures only those men most at risk of having cancer undergo an invasive biopsy.</p><p>Alongside cutting-edge research, we are helping more people get diagnosed earlier for cancer and other conditions by rolling out additional tests, checks and scans at 160 locations across England through our Community Diagnostics Centres programme.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 24500 question first answered 08/05/2024 15:44:24 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4504 label Biography information for Wes Streeting